Delox develops biodecontamination systems for healthcare, pharmaceuticals, Industry 4.0, biodefence and space. Its system enables hospitals and laboratories to acquire biodecontamination at an affordable price and without recourse to third parties.
An initiative of:
Co-awarded and supported by:
